Yazdian-Robati Rezvan, Arab Atefeh, Ramezani Mohammad, Abnous Khalil, Taghdisi Seyed Mohammad
Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Nanotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Int J Pharm. 2017 Aug 30;529(1-2):44-54. doi: 10.1016/j.ijpharm.2017.06.058. Epub 2017 Jun 23.
Leukemia is a cancer of blood cells and bone marrow, leading to death in many patients mainly in children. Over the last several years, aptamers generated by SELEX (Systematic evolution of ligands by exponential enrichment) method, have quickly become a new class of targeting ligands for drug delivery applications and recently have been widely exploited in different biomedical applications, due to several potent properties such as high binding affinity and selectivity, low or no immunogenicity and toxicity, low cost and thermal stability. In this review, we presented in details about aptamers involved in targeting, and treatment of leukemia. Moreover, some analytical approaches such as electrochemical and optical aptasensors were introduced for detection and diagnosis of leukemia. Finally, we discussed about the directions and challenges of aptamer application in this field.
白血病是一种血细胞和骨髓的癌症,主要导致许多儿童患者死亡。在过去几年中,通过指数富集配体系统进化(SELEX)方法产生的适体迅速成为一类新型的药物递送应用靶向配体,并且由于其具有高结合亲和力和选择性、低免疫原性和毒性、低成本以及热稳定性等多种强大特性,最近已在不同的生物医学应用中得到广泛应用。在本综述中,我们详细介绍了参与白血病靶向和治疗的适体。此外,还介绍了一些用于白血病检测和诊断的分析方法,如电化学和光学适体传感器。最后,我们讨论了适体在该领域应用的方向和挑战。